We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Multi-Pathogen Tests Optimized for Two Automated Systems

By Labmedica staff writers
Posted on 06 May 2008
Tests based on multiplexing polymerase chain reaction (PCR) technology, which enable detection of multiple pathogens in a single tube, have been optimized for two automated systems. More...
This will allow these tests to be performed throughout a wide spectrum of labs, from small to mid-sized labs to large commercial reference labs.

Called Seeplex and developed by Seegene (Rockville, MD, USA, and Seoul, Republic of Korea), the tests deliver maximum specificity, reproducibility, and sensitivity and can be applied to a broad range of molecular diagnostics, including human, animal, plant, and microorganism. Currently, Seegene's Seeplex multi-pathogen detection tests offer labs worldwide simple, cost-effective, and comprehensive screening for sexually transmitted diseases (STDs), respiratory viruses, human Papillomaviruses, sepsis, and pneumonia.

The Seeplex multi-pathogen tests are now optimized for Lab 901's (Midlothian, UK) ScreenTape and Caliper LifeSciences' (Hopkinton, MA, USA) LC90 automated detection systems. The ScreenTape system is the first fully automated, walk-away solution for gel electrophoresis. ScreenTape will automate the simultaneous analysis of eight or sixteen Seeplex PCR samples. The processing speed for eight samples is less than 10 minutes; 16 samples less than 15 minutes. ScreenTape displays results using easy to interpret color codes. The ScreenTape system comprises the TapeStation (that carries out liquid handling, electrophoresis, and imaging), ScreenTape (a consumable that contains the pre-cast, pre-packaged gel and running buffer), and custom software. With no gel or buffer preparation and no system priming, even untrained operators can rapidly generate accurate and reproducible test data.

The LabChip 90 (LC90) system performs fast, automated, 1-D electrophoretic separations of protein, DNA, and RNA samples directly from a 96 or 384 well plate. The LC90 can load and read 96 Seeplex samples within 45 minutes or 384 Seeplex samples in four hours in easy-to-interpret reports.

Seegene is currently working to optimize Seeplex tests for other automated capillary electrophoresis systems. Seeplex's compatibility with a wide range of automated detection systems will provide end-users with the flexibility to use the platform best suited for their purposes.

Seegene applies its novel and proprietary Seeplex system utilizing DPO (dual priming oligo) and ACP (annealing control primer) to create multi-pathogen tests delivering maximum specificity, reproducibility, and sensitivity. Seegene's mission is to integrate Seeplex with disease diagnostics to provide a new guideline for effectively treating patients


Related Links:
Seegene
Lab 901
Caliper LifeSciences

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.